Tingson, Cherame P.
HRN: 21-82-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
CEFUROXIME 500MG (TAB)
08/25/2022
09/01/2022
PO
500mg
Q12
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Duration Wrong Duration
Overall appropriateness: No Wrong Duration